The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparing clinician- and patient-rated performance status and association with psychosocial status in advanced genitourinary cancer.
 
Cristiane Decat Bergerot
No Relationships to Disclose
 
Paulo Gustavo Bergerot
No Relationships to Disclose
 
Errol James Philip
No Relationships to Disclose
 
Joann Hsu
No Relationships to Disclose
 
Nazli Dizman
No Relationships to Disclose
 
Meghan Salgia
No Relationships to Disclose
 
Dena Battle
Honoraria - EMD Serono; Exelixis; Novartis
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - EMD Serono; Exelixis; Novartis
Other Relationship - Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Merck; Pfizer/EMD Serono
 
Ulka N. Vaishampayan
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Exelixis; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Exelixis; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Pfizer
 
Matthew J. Loscalzo
Employment - Puma Biotechnology (I)
Honoraria - Puma Biotechnology (I)
Patents, Royalties, Other Intellectual Property - SupportScreen royalties via my employer City of Hope (non profit)
 
William Dale
No Relationships to Disclose
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Eisai; Exelixis; Genentech; Ipsen; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation